beta blocker: CAN can given to asthmatics

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
CAN can given to asthmatics 1.00
be bad for asthma 0.82
affect asthma 0.81
CAN can given 0.80
make asthma worse 0.80
be contraindicated in patients with asthma 0.78
be bad for diabetics 0.78
cause asthma attacks 0.77
be contraindicated with asthma 0.76
be contraindicated in asthma 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.46
Rule weight: 0.66
Evidence weight: 0.89
Similarity weight: 0.78
Evidence: 0.73
Plausible(high blood pressure, be bad for diabetics) ⋁
Evidence: 0.41
¬ Typical(beta blocker, CAN can given to asthmatics)

Plausibility inheritance from parent to child

0.04
Rule weight: 0.09
Evidence weight: 0.58
Similarity weight: 0.78
Evidence: 0.42
Plausible(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.73
¬ Plausible(high blood pressure, be bad for diabetics)

Remarkability exclusitivity betweem a parent and a child

0.35
Rule weight: 0.58
Evidence weight: 0.79
Similarity weight: 0.78
Evidence: 0.64
¬ Remarkable(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.33
¬ Remarkable(high blood pressure, be bad for diabetics)

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.58
Similarity weight: 0.76
Evidence: 0.64
¬ Remarkable(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.65
¬ Remarkable(atenolol, be contraindicated in asthma)

Remarkability from parent implausibility

0.31
Rule weight: 0.42
Evidence weight: 0.96
Similarity weight: 0.78
Evidence: 0.73
Plausible(high blood pressure, be bad for diabetics) ⋁
Evidence: 0.64
Remarkable(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.42
¬ Plausible(beta blocker, CAN can given to asthmatics)

Remarkability from sibling implausibility

0.39
Rule weight: 0.60
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.42
Plausible(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.65
Remarkable(atenolol, be contraindicated in asthma) ⋁
Evidence: 0.75
¬ Plausible(atenolol, be contraindicated in asthma)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.73
Similarity weight: 1.00
Evidence: 0.42
Plausible(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.46
¬ Salient(beta blocker, CAN can given to asthmatics)

Similarity expansion

0.56
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.82
Evidence: 0.64
Remarkable(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.57
¬ Remarkable(beta blocker, be bad for asthma)
0.51
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.81
Evidence: 0.41
Typical(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.44
¬ Typical(beta blocker, affect asthma)
0.51
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.78
Evidence: 0.64
Remarkable(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.67
¬ Remarkable(beta blocker, be contraindicated in patients with asthma)
0.50
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.78
Evidence: 0.64
Remarkable(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.69
¬ Remarkable(beta blocker, be bad for diabetics)
0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.64
Remarkable(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.68
¬ Remarkable(beta blocker, be contraindicated with asthma)
...

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.46
Salient(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.41
¬ Typical(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.64
¬ Remarkable(beta blocker, CAN can given to asthmatics)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.42
Plausible(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.41
¬ Typical(beta blocker, CAN can given to asthmatics)

Typicality and Rermarkability incompatibility between a parent and a child

0.17
Rule weight: 0.51
Evidence weight: 0.43
Similarity weight: 0.78
Evidence: 0.64
¬ Remarkable(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.88
¬ Typical(high blood pressure, be bad for diabetics)

Typicality and Rermarkability incompatibility between siblings

0.05
Rule weight: 0.14
Evidence weight: 0.50
Similarity weight: 0.76
Evidence: 0.64
¬ Remarkable(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.79
¬ Typical(atenolol, be contraindicated in asthma)

Typicality inheritance from parent to child

0.18
Rule weight: 0.48
Evidence weight: 0.48
Similarity weight: 0.78
Evidence: 0.41
Typical(beta blocker, CAN can given to asthmatics) ⋁
Evidence: 0.88
¬ Typical(high blood pressure, be bad for diabetics)